Navigation Links
Navigating Cancer Announces Jeff Oberlander as VP, Engineering

SEATTLE, Jan. 29, 2013 /PRNewswire/ -- Navigating Cancer is proud to announce that Jeff Oberlander has joined Navigating Cancer as VP, Engineering. Jeff has over 23 years of software engineering development and leadership expertise from a wide variety of company sizes, from 120,000-employee Fortune 500 companies to a variety of small startups in the Seattle area.

Oberlander joins a growing Navigating Cancer team, which has developed the leading patient portal in the oncology market and now delivers patient engagement solutions to nearly 600 oncologists across the United States. With a mix of healthcare and technology industry veterans, Navigating Cancer is poised to build on this leadership position and plans to grow its market share aggressively in the coming year. In his new role, Jeff will lead the engineering team to scale its current technology platform for growth and address the many business opportunities that are opening in front of the company. This will include expanding the team, as well as working towards a service-oriented architecture in order to extend the capabilities of the platform and allow for the anticipated growth of the business.

Most recently, Jeff was the Senior Director, Software Engineering for Getty Images, where he led all of Getty's Seattle eCommerce web development teams. Over the last 8 years, his teams created mission critical, 24x7, high volume eCommerce sites (80 million images, 6 million searches a day) that led to Getty's nearly $1B annual revenue. Jeff is also a passionate leader and coach in lean and agile software development best practices, which strives to bring visibility to the business value of software being created, visibility of prioritization, and a focus on the flow of work from "concept to cash." He led the transformation of Getty's 200+ IT staff to adopt these new principles and processes.

"We've been searching for the right engineering leader for over a year," said Gena Cook , Navigating Cancer CEO. "We're excited to have Jeff's leadership, expertise, vision and passion to help scale our business to better serve the healthcare professionals and patients we serve every day."

"I am thrilled to have this chance to work in such a meaningful and personal business. Everyone I know has been touched in some way by cancer, and this business helps cancer patients manage their care in a way that wasn't available previously. The business is growing quickly and customers are signing up at a rapid pace — yet it has all of the fun of a new startup where everyone contributes to the bottom line and wears many hats. It is exciting to be able to apply the breadth of my technology experience to a new growing Seattle business, and one that will make a difference to others," said Oberlander.

About Navigating Cancer

Navigating Cancer's mission is to transform healthcare through patient centered care by using technology to connect cancer patients to their healthcare team, their own health records, and the right information at the right time. Navigating Cancer's Patient Engagement Portal provides oncology clinics with a branded, online extension of their care model, empowering them to save time and money while providing better quality care. The company was founded in 2008 by technology and healthcare veterans and is based in Seattle, Washington.

SOURCE Navigating Cancer
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. 500 Oncology Providers Sign Up for Navigating Cancers Patient Engagement Portal
2. MarketsandMarkets: Lung Cancer Drugs Market in G7 Countries Worth $13 Billion by 2020
3. Virobays Spectrum-Selective Cathepsin Inhibitor Shows Efficacy in Bone Cancer Model
4. Biocept and Academic Collaborators to Present Posters at San Antonio Breast Cancer Symposium on Circulating Tumor Cells (CTCs)
5. NKTR-102 Demonstrates Synergistic Anti-Tumor Activity in Combination with Pegylated Liposomal Doxorubicin in Platinum-Resistant Ovarian Cancer
6. Members of Congress, Cancer Experts Address Impact of Genetic Testing on Cancer
7. Masaryk Memorial Cancer Institute Reduces Losses and Administrative Overhead With Ekahau RTLS
8. BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelonas Vall dHebron Hospital in Biomarker Research for Personalized Cancer Therapies
9. MarketsandMarkets: Global Prostate Cancer Therapeutics Market worth $6,457 Million by 2020
10. New research points to benefits of innovative cobas® HPV test for primary screening as Englands cervical cancer screening programme includes the test in current HPV "triage" rollout
11. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
Post Your Comments:
(Date:11/24/2015)... Mass. (PRWEB) , ... November 24, 2015 , ... ... to maintain healthy metabolism. But unless it is bound to proteins, copper is ... of Health (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... ... , ... The Academy of Model Aeronautics (AMA), led by its Executive Council, ... Grand Prix, to represent the First–Person View (FPV) racing community. , FPV racing has ... type of racing and several new model aviation pilots have joined the community because ...
(Date:11/24/2015)... Israel , Nov. 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) ... on December 29, 2015 at 11:00 a.m. Israel ... Electra Tower, 98 Yigal Allon Street, 36 th Floor, ... of Eric Paneth and Izhak Tamir to the ... Rami Skaliter as external directors; , approval of an amendment to ...
Breaking Biology Technology:
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
(Date:10/29/2015)... 29, 2015  The J. Craig Venter Institute (JCVI) ... Synthesis and Biosecurity: Lessons Learned and Options for the ... and Human Services guidance for synthetic biology providers has ... --> --> Synthetic biology ... potential to pose unique biosecurity threats. It now is ...
(Date:10/29/2015)... ANN ARBOR, Mich. , Oct. 29, 2015 ... with Eurofins Genomics for U.S. distribution of its ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq ... DNA to enable the preparation of NGS libraries ... in plasma for diagnostic and prognostic applications in ...
Breaking Biology News(10 mins):